SUBSCRIBERS
Bangladesh company offering cheap copy of Gilead's blockbuster hep C drug
Add BT as a preferred sourcePublished Tue, Mar 10, 2015 · 09:50 PM
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Mumbai
A US$10 version of Sovaldi, the Gilead Sciences Inc hepatitis C treatment that sells for US$1,000 a pill in the US, is now available in Bangladesh and could make its way to other parts of the world where the US company doesn't have patents.
Incepta Pharmaceuticals Ltd doesn't have a licence from Gilead and its version was launched last month, said managing director Abdul Muktadir. The company also aims to sell the drug overseas, including to parts of South-east Asia and Africa.
Share with us your feedback on BT's products and services
